These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 17669856)

  • 1. Association between prothrombin activation fragment (F1.2), cerebral ischemia (S-100beta) and international normalized ratio (INR) in patients with ventricular assisted devices.
    Joshi A; Magder LS; Kon Z; Kallam S; Kwon M; Sangrampurkar R; Pierson R; Poston R
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):323-7. PubMed ID: 17669856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation.
    Koefoed BG; Feddersen C; Gulløv AL; Petersen P
    Thromb Haemost; 1997 May; 77(5):845-8. PubMed ID: 9184390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral anticoagulant therapy and international normalized ratios in swine.
    McGlasson DL; Brickey DA; Doe RH
    Lab Anim Sci; 1998 Aug; 48(4):371-3. PubMed ID: 10090045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.
    Jonsson M; Hillarp A; Svensson P
    Thromb Res; 2004; 114(2):83-9. PubMed ID: 15306149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of different oral anticoagulant intensities on prothrombin fragment 1 + 2 in Thai patients with mechanical heart valve prostheses.
    Tientadakul P; Opartkiattikul N; Sangtawesin W; Sakiyalak P
    J Med Assoc Thai; 1997 Feb; 80(2):81-6. PubMed ID: 9078691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin III complex(TAT) and thrombophilia parameters in orally anticoagulated patients with inferior vena cava filters].
    Halbmayer WM; Haushofer A; Toth E
    Wien Med Wochenschr; 1993; 143(5):95-8. PubMed ID: 8511904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal of warfarin after deep vein thrombosis: effects of a low fixed dose on rebound thrombin generation.
    Ascani A; Iorio A; Agnelli G
    Blood Coagul Fibrinolysis; 1999 Jul; 10(5):291-5. PubMed ID: 10456621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of prothrombin fragment F1+2 to monitor the effect of oral anticoagulation.
    Bruhn HD; Zurborn KH
    J Heart Valve Dis; 1995 Mar; 4(2):138-40. PubMed ID: 8556173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolism.
    Kyrle PA; Eichinger S; Pabinger I; Stümpflen A; Hirschl M; Bialonczyk C; Schneider B; Mannhalter C; Melichart M; Traxler G; Weltermann A; Speiser W; Lechner K
    Thromb Haemost; 1997 May; 77(5):829-33. PubMed ID: 9184387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [International normalized ratio (INR) for optimal anticoagulant therapy].
    Uetsuka Y; Katsuki T; Aosaki M; Iwade K; Hashimoto A; Koyanagi H; Saito M; Yaginuma Y; Hosoda S
    Kokyu To Junkan; 1993 Sep; 41(9):885-90. PubMed ID: 8210749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement.
    Eitz T; Schenk S; Fritzsche D; Bairaktaris A; Wagner O; Koertke H; Koerfer R
    Ann Thorac Surg; 2008 Mar; 85(3):949-54; discussion 955. PubMed ID: 18291177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators.
    Feinberg WM; Cornell ES; Nightingale SD; Pearce LA; Tracy RP; Hart RG; Bovill EG
    Stroke; 1997 Jun; 28(6):1101-6. PubMed ID: 9183333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation.
    Boyle AJ; Russell SD; Teuteberg JJ; Slaughter MS; Moazami N; Pagani FD; Frazier OH; Heatley G; Farrar DJ; John R
    J Heart Lung Transplant; 2009 Sep; 28(9):881-7. PubMed ID: 19716039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicentric evaluation of a new assay for prothrombin fragment F1+2 determination.
    Bruhn HD; Conard J; Mannucci M; Monteagudo J; Pelzer H; Reverter JC; Samama M; Tripodi A; Wagner C
    Thromb Haemost; 1992 Oct; 68(4):413-7. PubMed ID: 1448772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma coagulation markers in patients with solid tumors and venous thromboembolic disease receiving oral anticoagulation therapy.
    Sallah S; Husain A; Sigounas V; Wan J; Turturro F; Sigounas G; Nguyen NP
    Clin Cancer Res; 2004 Nov; 10(21):7238-43. PubMed ID: 15534097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of molecular markers for administration of anticoagulant therapy after heart valve replacement].
    Dahm M; Lotz J; Hafner G; Oelert H; Prellwitz W
    Z Kardiol; 1998; 87 Suppl 4():42-5. PubMed ID: 9857466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.